HKD 3.45
(-0.29%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 5.18 Billion CNY | -7.37% |
2022 | 5.6 Billion CNY | 9.17% |
2021 | 5.12 Billion CNY | 48.36% |
2020 | 3.45 Billion CNY | 29.62% |
2019 | 2.66 Billion CNY | -17.8% |
2018 | 3.24 Billion CNY | 451.96% |
2017 | 587.92 Million CNY | 4.98% |
2016 | 560.03 Million CNY | 190.36% |
2015 | 192.87 Million CNY | 35.99% |
2014 | 141.83 Million CNY | 70.14% |
2013 | 83.36 Million CNY | -38.8% |
2012 | 136.2 Million CNY | 21.01% |
2011 | 112.55 Million CNY | -18.34% |
2010 | 137.84 Million CNY | 5.91% |
2009 | 130.15 Million CNY | 12.68% |
2008 | 115.5 Million CNY | -33.53% |
2007 | 173.78 Million CNY | -71.86% |
2006 | 617.59 Million CNY | -10.25% |
2005 | 688.15 Million CNY | 387.3% |
2004 | 141.21 Million CNY | -21.08% |
2003 | 178.93 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q4 | 5.18 Billion CNY | 0.0% |
2023 Q2 | 5.37 Billion CNY | 0.0% |
2023 FY | 5.18 Billion CNY | -7.37% |
2022 FY | 5.6 Billion CNY | 9.17% |
2022 Q2 | 5.4 Billion CNY | 0.0% |
2022 Q4 | 5.6 Billion CNY | 0.0% |
2021 Q4 | 5.12 Billion CNY | 0.0% |
2021 FY | 5.12 Billion CNY | 48.36% |
2021 Q2 | 5.6 Billion CNY | 0.0% |
2020 Q2 | 2.73 Billion CNY | 0.0% |
2020 FY | 3.45 Billion CNY | 29.62% |
2020 Q4 | 3.45 Billion CNY | 0.0% |
2019 Q2 | 3.05 Billion CNY | 0.0% |
2019 Q4 | 2.66 Billion CNY | 0.0% |
2019 FY | 2.66 Billion CNY | -17.8% |
2018 Q4 | 3.24 Billion CNY | 0.0% |
2018 FY | 3.24 Billion CNY | 451.96% |
2018 Q2 | 2.84 Billion CNY | 0.0% |
2017 Q4 | 587.92 Million CNY | 0.0% |
2017 Q2 | 805.69 Million CNY | 0.0% |
2017 FY | 587.92 Million CNY | 4.98% |
2016 FY | 560.03 Million CNY | 190.36% |
2016 Q4 | 560.03 Million CNY | 0.0% |
2016 Q2 | 370.94 Million CNY | 0.0% |
2015 FY | 192.87 Million CNY | 35.99% |
2015 Q4 | 192.87 Million CNY | 0.0% |
2015 Q2 | 189.61 Million CNY | 0.0% |
2014 FY | 141.83 Million CNY | 70.14% |
2014 Q2 | 128.99 Million CNY | 0.0% |
2014 Q4 | 141.83 Million CNY | 0.0% |
2013 Q2 | 82.61 Million CNY | -0.14% |
2013 Q4 | 83.36 Million CNY | -24.87% |
2013 Q3 | 110.95 Million CNY | 34.3% |
2013 FY | 83.36 Million CNY | -38.8% |
2013 Q1 | 82.72 Million CNY | -39.26% |
2012 Q3 | 90.34 Million CNY | -30.99% |
2012 FY | 136.2 Million CNY | 21.01% |
2012 Q2 | 130.9 Million CNY | -1.1% |
2012 Q4 | 136.2 Million CNY | 50.76% |
2012 Q1 | 132.36 Million CNY | 17.59% |
2011 FY | 112.55 Million CNY | -18.34% |
2011 Q2 | 133.11 Million CNY | 0.0% |
2011 Q4 | 112.55 Million CNY | 0.0% |
2010 Q2 | 130.46 Million CNY | 0.0% |
2010 FY | 137.84 Million CNY | 5.91% |
2010 Q4 | 137.84 Million CNY | 0.0% |
2009 Q4 | 130.15 Million CNY | 0.0% |
2009 FY | 130.15 Million CNY | 12.68% |
2008 FY | 115.5 Million CNY | -33.53% |
2007 FY | 173.78 Million CNY | -71.86% |
2006 FY | 617.59 Million CNY | -10.25% |
2005 FY | 688.15 Million CNY | 387.3% |
2004 FY | 141.21 Million CNY | -21.08% |
2003 FY | 178.93 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
China Healthwise Holdings Limited | 145.27 Million HKD | -3471.048% |
Tycoon Group Holdings Limited | 445.4 Million HKD | -1064.723% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 413.75 Million HKD | -1153.818% |